Glucose

interleukin 6 ; Homo sapiens







292 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
251 16235156 Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. 2005 Oct 1
252 16356228 Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630]. 2005 1
253 14676217 High glucose enhances interleukin-6-induced vascular endothelial growth factor 165 expression via activation of gp130-mediated p44/42 MAPK-CCAAT/enhancer binding protein signaling in gingival fibroblasts. 2004 Feb 20 3
254 15001458 Modulation of PPARalpha expression and inflammatory interleukin-6 production by chronic glucose increases monocyte/endothelial adhesion. 2004 May 1
255 15180970 Influence of the interleukin-6 -174 G/C gene polymorphism on exercise training-induced changes in glucose tolerance indexes. 2004 Oct 4
256 15304054 Intermittent high glucose enhances ICAM-1, VCAM-1, E-selectin and interleukin-6 expression in human umbilical endothelial cells in culture: the role of poly(ADP-ribose) polymerase. 2004 Aug 2
257 15381186 The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome. 2004 Oct 21 2
258 15528032 Protective effects of 17beta-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: relevance to heart disease in postmenopausal women. 2004 Dec 1 1
259 15569129 Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone. 2004 Dec 2
260 12509497 The effect of graded exercise on IL-6 release and glucose uptake in human skeletal muscle. 2003 Jan 1 6
261 12540635 The C-174G promoter polymorphism of the IL-6 gene affects energy expenditure and insulin sensitivity. 2003 Feb 1
262 12702735 Glucose ingestion attenuates interleukin-6 release from contracting skeletal muscle in humans. 2003 Jun 1 3
263 12918129 Influence of acute hyperglycemia in human sepsis on inflammatory cytokine and counterregulatory hormone concentrations. 2003 Aug 1
264 12952969 Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects. 2003 Nov 14 1
265 14519071 The therapeutic potential of interleukin-6 in treating obesity. 2003 Oct 1
266 14605496 Glucose-induced changes in the phenotype of human peritoneal mesothelial cells: effect of L-2-oxothiazolidine carboxylic acid. 2003 Nov-Dec 2
267 14686093 The role of IL-6 in exercise-induced immune changes and metabolism. 2003 1
268 11961304 Effects of high glucose on interleukin-6 production in human mesangial cells. 2002 Apr 7
269 11994345 Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. 2002 May 1
270 12006357 Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. 2002 Jun 2
271 12107724 Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors. 2002 Jun 1
272 12379575 Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. 2002 Oct 15 1
273 12388119 IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. 2002 Dec 1
274 11687509 Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. 2001 Dec 1
275 11739520 Cytokine regulation of facilitated glucose transport in human articular chondrocytes. 2001 Dec 15 1
276 10868978 Interleukin-6 gene polymorphism and insulin sensitivity. 2000 Mar 3
277 11079743 High glucose modulates P2X7 receptor-mediated function in human primary fibroblasts. 2000 Oct 1
278 11225716 Raised interleukin-6 levels in obese patients. 2000 Dec 2
279 9501294 Elevated amniotic fluid nitric oxide metabolites and interleukin-6 in intra-amniotic infection. 1998 Jan-Feb 1
280 9648083 Effect of alternative peritoneal dialysis solutions on cell viability, apoptosis/necrosis and cytokine expression in human monocytes. 1998 Jul 3
281 9853701 Portal but not peripheral serum levels of interleukin 6 could interfere with glucose metabolism in patients with pancreatic cancer. 1998 Oct 1
282 11061332 High glucose concentrations increase the tumor necrosis factor-alpha production capacity by human peripheral blood mononuclear cells. 1998 Jul-Dec 1
283 9134917 Carbohydrate and the cytokine response to 2.5 h of running. 1997 May 1
284 9398733 Dose-dependent effects of recombinant human interleukin-6 on glucose regulation. 1997 Dec 5
285 8648229 Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis. 1996 Jun 1
286 8666148 Glucose-dependent interleukin 6 and tumor necrosis factor production by human peripheral blood monocytes in vitro. 1996 Jul 5
287 8769856 Exposure of astrocytes to hypoxia/reoxygenation enhances expression of glucose-regulated protein 78 facilitating astrocyte release of the neuroprotective cytokine interleukin 6. 1996 Mar 1
288 8811326 Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. 1996 Jun 4
289 7695204 The effect of glucose and advanced glycosylation end products on IL-6 production by human monocytes. 1995 Jan 17 5
290 7628063 Endocrine and carbohydrate responses to interleukin-6 in vivo. 1994 Dec 1
291 2105658 Interleukin 6 stimulates hepatic glucose release from prelabeled glycogen pools. 1990 Jan 3
292 2674559 Possible role of IL-1, TNF-alpha, and IL-6 in insulin-dependent diabetes mellitus and autoimmune thyroid disease. Thyroid Cell Group. 1989 Fall 1